Prof. Lowell Parsons Presents Urigen at One Med Place Conference in San Francisco on Jan. 13 at 4PM
2010-01-13 09:25 ET - News Release
SAN FRANCISCO -- (Business Wire)
Urigen Pharmaceuticals, Inc. (OTCBB:URGP), a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that Urigen’s scientific founder, Prof. Lowell Parsons, MD will present the company at 4pm Wednesday, January 13, 2010 at the One Med Place conference located at the Sir Francis Drake Hotel, 450 Powell Street, Union Square, San Francisco.
C. Lowell Parsons, M.D., a director of Urigen, is a leader in medical research into the causes and treatment of interstitial cystitis, which is a painful bladder syndrome with typical cystoscopic and/or histological features in the absence of infection or other pathology, and has published over 200 scientific articles and book chapters in this area describing his work. Dr. Parsons received his M.D. degree from the Yale University School of Medicine in New Haven, CT, in 1970. After completing his medical internship at Yale in 1971, Dr. Parsons spent two years as a staff associate in the Laboratory of Microbiology at the National Institutes of Health in Bethesda, Maryland. He then completed his urology residency training at the Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, in 1977. Dr. Parsons joined the Division of Urology faculty at the University of California, San Diego, or UCSD, in 1977 as assistant professor. He served as Chief of Urology at the UCSD-affiliated Veterans Affairs Medical Center in La Jolla from 1977 to 1985. Since 1988, he has been Professor of Surgery/Urology.
About Urigen Pharmaceuticals, Inc.
